Skip to content
  • Members
  • Resources
  • Contact us
  • Generic selectors
    Exact matches only
    Search in title
    Search in content
    Post Type Selectors

Eurordis - Rare Disease Europe

Sobre nós

Encontre-nos

Como operamos

Nossa rede

Sobre nossas prioridades

Áreas prioritárias

Leia nossas últimas posições políticas

Obter informação

Trova supporto

Com EURORDIS

Com nossos programas e iniciativas

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Atualidades
Eventos
Members
Resources
Contact us
Opções de acessibilidade
Language
Donate

EURORDIS Round Table of Companies (ERTC)

ERTC Code of ConductERTC Code of ConductJulho 2022Download
33rd EURORDIS Round Table of Companies Workshop33rd EURORDIS Round Table of Companies WorkshopMaio 2022Read More
32nd EURORDIS Round Table of Companies Workshop32nd EURORDIS Round Table of Companies WorkshopOutubro 2021Read More
31st EURORDIS Round Table of Companies Workshop31st EURORDIS Round Table of Companies WorkshopMarço 2021Read More
30th EURORDIS Round Table of Companies Workshop30th EURORDIS Round Table of Companies WorkshopJulho 2020Read More
29th EURORDIS Round Table of Companies Workshop29th EURORDIS Round Table of Companies WorkshopDezembro 2019Read More
28th EURORDIS Round Table of Companies Workshop28th EURORDIS Round Table of Companies WorkshopJunho 2019Read More
3rd EURORDIS Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease Therapies3rd EURORDIS Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease TherapiesFevereiro 2019Read More
27th EURORDIS Round Table of Companies Workshop27th EURORDIS Round Table of Companies WorkshopAbril 2018Read More
26th EURORDIS Round Table of Companies Workshop26th EURORDIS Round Table of Companies WorkshopDezembro 2017Read More
25th EURORDIS Round Table of Companies Workshop25th EURORDIS Round Table of Companies WorkshopAgosto 2017Read More
2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease Therapies2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease TherapiesOutubro 2016Read More
24th Workshop of the EURORDIS Round Table of Companies: “Bringing solutions to young rare disease patients”24th Workshop of the EURORDIS Round Table of Companies: “Bringing solutions to young rare disease patients”Julho 2016Read More
1st Multi-stakeholder Symposium on Improving Patient Access to Rare Disease Therapies1st Multi-stakeholder Symposium on Improving Patient Access to Rare Disease TherapiesDezembro 2015Read More
23rd Workshop, Barcelona: “Patient Relevant Outcome Measures & Patient Reported Outcomes”23rd Workshop, Barcelona: “Patient Relevant Outcome Measures & Patient Reported Outcomes”Julho 2015Read More
22nd Workshop, Brussels: “Rare Diseases: Going Global”22nd Workshop, Brussels: “Rare Diseases: Going Global”Janeiro 2015Read More
21st Workshop, Barcelona: “Sharing Rare Disease Patient Data: Translating Principles into Action”21st Workshop, Barcelona: “Sharing Rare Disease Patient Data: Translating Principles into Action”Junho 2014Read More
20th ERTC Workshop, Brussels: “Unlocking Europe’s Potential in Rare Disease Therapies”20th ERTC Workshop, Brussels: “Unlocking Europe’s Potential in Rare Disease Therapies”Janeiro 2014Read More
19th Workshop, Barcelona: “Practical aspects of progressive patient access to OMPs, post-marketing evidence generation and related pricing questions”19th Workshop, Barcelona: “Practical aspects of progressive patient access to OMPs, post-marketing evidence generation and related pricing questions”Agosto 2013Read More
15th Workshop, Paris: “Compassionate Access to Rare Disease Therapies”15th Workshop, Paris: “Compassionate Access to Rare Disease Therapies”Março 2013Read More
17th Workshop, Barcelona: “The Value of Orphan Drugs: Efficient for the Patients, Useful to Society?”17th Workshop, Barcelona: “The Value of Orphan Drugs: Efficient for the Patients, Useful to Society?”Março 2013Read More
16th Workshop, Brussels: “The Value of Partnering in Rare Disease Therapies”16th Workshop, Brussels: “The Value of Partnering in Rare Disease Therapies”Março 2013Read More
18th Workshop, Brussels: “Corporate Responsibility in Improving Access to Orphan Medicinal Products”Março 2013Read More
13th Workshop, Paris: “Patients’ Access to OMPs, Innovative Pricing Schemes and National Measures in a Global Financial and Economic Crisis Environment”Março 2013Read More
14th Workshop, Barcelona: “Mechanisms for the Implementation of the Clinical Added-Value (Relative Effectiveness) of Orphan Drugs, CAVOD”Março 2013Read More
12th Workshop, Barcelona: “Retooling the EU Orphan Drug Regulation and US Orphan Drug Act for Better and Faster Development of Rare Disease Therapies”Março 2013Read More
10th Workshop, Barcelona: “EURORDIS Strategy 2010-2015 and Partnership with the ERTC Members”Março 2013Read More
11th Workshop, Paris: “Improving Access to Orphan Drugs for all Patients affected by Rare Diseases in Europe: EU Assessment of Clinical Added-Value of Orphan Drugs (CAVOD)”Março 2013Read More
8th Workshop, Barcelona: “Impact of the EU Paediatric Regulation on Orphan Drug Development”Março 2013Read More
7th Workshop, Paris: “Proof of Concept and Level of Evidence in Orphan Drug Development”Março 2013Read More
5th Workshop, Paris: “Rare Disease Patient Registries: an Essential Tool in the Development of Therapies?”Março 2013Read More
1st Workshop, Barcelona: “Compassionate Access Programmes for Orphan Drugs in Europe: from Heterogeneity to Harmonised Practices?”Março 2013Read More
9th Workshop, Paris: “Significant Benefit of Orphan Drugs:Impact on Clinical Development and Assessment”Dezembro 2008Read More
6th Workshop, Barcelona: “Do Rare Disease Patients Have Real Access to Orphan Drugs in Europe?”Junho 2007Read More
4th Workshop, Barcelona: “Common Drugs for Common Needs:the US vs EU Approach to OMP Development”Junho 2006Read More
3rd Workshop, Barcelona: “Rare Disease Clinical Trials: Ensuring Fruitful Collaborations between Sponsors & Patient Organisations”Novembro 2005Read More
2nd Workshop, Paris: “New Methodologies for Clinical Trials in Small Populations”Julho 2005Read More
This site is registered on wpml.org as a development site.